Benefit from adrenocorticotrophin in myasthenia gravis
Open Access
- 1 April 1974
- journal article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 37 (4) , 412-415
- https://doi.org/10.1136/jnnp.37.4.412
Abstract
Twenty-one of 29 patients suffering from myasthenia gravis derived benefit from a short intensive course of adrenocorticotrophin (ACTH). The mean duration of benefit was approximately six months. The best results were obtained in patients with a short history of myasthenia. Transient deterioration during the course of injections was encountered in some cases but necessitated assisted respiration only in patients with severe generalized weakness before treatment.Keywords
This publication has 10 references indexed in Scilit:
- RESULTS WITH ACTH AND SPIRONOLACTONE IN SEVERE CASES OF MYASTHENIA GRAVISActa Neurologica Scandinavica, 2009
- Corticosteroids in management of severe, generalized myasthenia gravisNeurology, 1972
- Corticotrophin therapy in myasthenia gravisNeurology, 1971
- Short-term intensive corticotrophin treatment in myasthenia gravis.1971
- Treatment of ocular myasthenia with corticotrophinJournal of Neurology, Neurosurgery & Psychiatry, 1971
- Treatment of myasthenia gravis with adrenocorticotropic hormone (ACTH): massive short-term and maintenance treatment.Journal of Neurology, Neurosurgery & Psychiatry, 1969
- Studies in myasthenia gravis. Short-term massive corticotropin therapy.1966
- THE PLACE OF CORTICOTROPIN IN THE TREATMENT OF MYASTHENIA GRAVISAnnals of Internal Medicine, 1960
- EFFECT OF ADRENOCORTICOTROPIC HORMONE (ACTH) AND CORTISONE ADMINISTRATION IN PATIENTS WITH MYASTHENIA GRAVIS AND REPORT OF ONSET OF MYASTHENIA GRAVIS DURING PROLONGED CORTISONE ADMINISTRATION1952
- EFFECTS OF ADMINISTRATION OF THE ADRENOCORTICOTROPIC HORMONE (ACTH) ON PATIENTS WITH MYASTHENIA GRAVISArchives of Neurology & Psychiatry, 1951